An analysis of four clinical trials involving more than 14,000 patients found that diabetes medication Avandia (rosiglitazone) taken over a lengthy period of time increases the risk of heart attack by 42 percent, a report released Tuesday said.
It marks one of the first studies to look at how use for one year or longer of Avandia, in patients with type 2 diabetes, affects risk of heart attack, heart failure and mortality, according to authors of the study in the September 12 issue of the Journal of The American Medical Association (JAMA).
Heart Attack
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Advertisement
The Food and Drug Administration recently required a label to be put on Avandia, made by British drugmaker GlaxoSmithKline, and similar treatments, warning of increased risk of heart failure.
An analysis of 42 short-term clinical studies published in May in the New England Journal of Medicine found that Avandia boosts heart attack risk by 43 percent.
![CPR - Cardiopulmonary Resuscitation - Animation]( "CPR - Cardiopulmonary Resuscitation - Animation")
CPR or CARDIOPULMONARY RESUSCITATION can restore function of the heart and lungs due to any condition that causes the heart to come to a stop. This usually happens after a massive heart-attack.
"The public health impact of potential harm with rosiglitazone is substantial," said Sonal Singh, MD, lead author and an assistant professor of internal medicine at Wake Forest. "Regulatory agencies should urgently evaluate whether this drug should remain on the market."
"There is no need for physicians, health plans or patients to wait for regulatory action," added Curt Furberg, a co-author of the report. "On the contrary, they should take prompt action and restrict the use of Avandia, especially since safer alternatives are available."
Source: AFP
SRM/J
CPR - Cardiopulmonary Resuscitation - Animation
CPR or CARDIOPULMONARY RESUSCITATION can restore function of the heart and lungs due to any condition that causes the heart to come to a stop. This usually happens after a massive heart-attack.
Advertisement
"The public health impact of potential harm with rosiglitazone is substantial," said Sonal Singh, MD, lead author and an assistant professor of internal medicine at Wake Forest. "Regulatory agencies should urgently evaluate whether this drug should remain on the market."
"There is no need for physicians, health plans or patients to wait for regulatory action," added Curt Furberg, a co-author of the report. "On the contrary, they should take prompt action and restrict the use of Avandia, especially since safer alternatives are available."
Source: AFP
SRM/J
Anti-diabetes Drug Improves Pregnancy Outcomes for Women With Insulin Resistance
A new study has revealed that a commonly prescribed anti-diabetes drug, Metformin, can potentially improve pregnancy outcomes in women having insulin resistance.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.